U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07472361) titled 'A Study of ENX-104 in Healthy Participants' on Feb. 24.
Brief Summary: The study is designed to evaluate the relative bioavailability, safety, and tolerability of a single dose of ENX-104 administered orally as a solution fasted, a tablet fasted, or a tablet with a high fat meal in healthy participants
Study Start Date: Feb. 25
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: ENX-104
Tablets
DRUG: ENX-104
Oral solution
Recruitment Status: RECRUITING
Sponsor: Engrail Therapeutics INC
Published by HT Digital Content Services with permission from Health Daily Digest....